STOCK TITAN

If You Invested in Kinnate Biopharma Inc. (KNTE)

NASDAQ
Looking for the current price? See the KNTE quote & overview
$1,000 invested 1 Year Ago
N/A
Trading since 2020-12-03
$1,000 invested 5 Years Ago
$111
-88.9% price return -59.5% CAGR
-88.9% with dividends reinvested
Bought on Oct 29, 2021 at $23.77 split-adjusted

What $1,000 or $10,000 in KNTE Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Dec 3, 2020
$1,000 — $111 -89% — $68 -93%
$10,000 — $1,115 -89% — $679 -93%

Based on real historical closing prices adjusted for stock splits, without dividends, through 2024-04-03. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for KNTE

$1,000 Investment Over Time

KNTE vs S&P 500

Year-by-Year Returns

KNTE annual performance
Year Start Price End Price Annual Return Cumulative
2020 $39.03 $39.78 +1.9% +1.9%
2021 $39.78 $17.72 -55.5% -54.6%
2022 $17.72 $6.10 -65.6% -84.4%
2023 $6.10 $2.37 -61.1% -93.9%
2024 $2.37 $2.65 +11.8% -93.2%

About Kinnate Biopharma Inc.

NASDAQ

Current Price
$2.65
View full KNTE overview

Frequently Asked Questions

Kinnate Biopharma Inc. investment returns

How much would $1,000 invested in Kinnate Biopharma Inc. be worth today?

If you invested $1,000 in Kinnate Biopharma Inc. (KNTE) 5 years ago on 2021-10-29, your investment would be worth $111 as of 2024-04-03, a -88.9% price return without dividends, growing at a compounded rate of -59.5% per year (CAGR).

Has Kinnate Biopharma Inc. outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare KNTE performance over available time periods.

What is Kinnate Biopharma Inc.'s average annual return?

The compound annual growth rate (CAGR) of KNTE’s share price over the past 5 years is -59.5%, without dividends. Individual years vary a great deal, and KNTE’s best recent full year was 2021 (-55.5%) while the worst was 2022 (-65.6%).

For informational and educational purposes only, not investment advice.